Astellas and Drais Partner to Develop Second Astellas Compound Through Seldar @Markwetwire @resilient_ent #VentureCapital

Astellas Pharma Inc. ("Astellas") and Drais Pharmaceuticals, Inc. ("Drais") today announced that they have entered into a second partnership in as many months to develop and commercialize an Astellas compound. Under the terms of the agreement, Astellas will transfer ownership of ASP7147, a bombesin BB2 receptor antagonist for the treatment of irritable bowel syndrome with diarrhea, from its pipeline to Seldar Pharma, Inc. ("Seldar"), a virtual company that will be operated by the Drais executive team.

The partnership is similar to one Astellas and Drais entered into in April to advance ASP3291 through Telsar, another virtual company. As with Telsar, Seldar will be operated by Drais, which has substantial clinical development experience.

READ MOTRE AS YOU ENTER THE WORLDS OF @WSJ @MARKETWATCH @MARKETWIRE benny quetell @resilient_ent resilient media entertainment venture capital

RESILIENT MEDIA ENTERTAINMENT

#PRIVATEEQUITY #VENTURECAPITAL, #HEDGEFUNDS, #INVESTMENTBANKING & a few fun things as well. Check US OUT: http://on.fb.me/vch6FQ http://linkd.in/oiB29lhttp://on.fb.me/sdaWqc http://bit.ly/uhH9hQ http://bit.ly/trKLuj http://goo.gl/Q376nkeywords: #PrivateEquity, #HedgeFunds, #VentureCapital, #InvestmentBanking, #AlernativeAssets, #CapitalMarkets, #MergersAndAcquisitions, #WallStreet, #IPO #ResilientMediaEntertainment, #IPO, @Resilient_Ent, #Film, #Music, #VideoGaming, #Media, #Fashion, #TV, #Technology #JointVentures #FaceBook #Magazines #PublicRelations #Radio #WealthManagementtags: +PrivateEquity, +HedgeFunds, +VentureCapital, +InvestmentBanking, +AlernativeAssets, +CapitalMarkets, +MergersAndAcquisitions, +WallStreet, +IPO +ResilientMediaEntertainment, +IPO, +@Resilient_Ent, +Film, +Music, +VideoGaming, +Media, +Fashion, +TV, +Technology +JointVentures +FaceBook, +Magazines +PublicRelations,+Radio, +WealthManagement